Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability and Pharmacokinetics of KAI-4169 in Healthy Male Volunteers
This study has been completed.
Study NCT01134549   Information provided by KAI Pharmaceuticals

First Received on May 28, 2010.   Last Updated on August 20, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperparathyroidism, Secondary
Additional conditions recognized in this trial
Hyperparathyroidism
More general conditions related to this trial
Endocrine System Diseases
Parathyroid Diseases
Interventions listed in this trial
KAI-4169
Saline
Sponsors listed in this trial
KAI Pharmaceuticals
Nucleus Network Ltd


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services